Therapeutic effect and tolerability of gelatin sponge particle-mediated chemoembolization for colorectal liver metastases: a retrospective study

详细信息    查看全文

• 作者：Chuang Li (3)
  Yuewei Zhang (3)
  Jun Zhou (3)
  Guangsheng Zhao (3)
  Shunxiong Tang (3)
  
• 关键词：Colorectal cancer ; Liver metastases ; GSP ; Chemoembolization
• 刊名：World Journal of Surgical Oncology
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：11
• 期：1
• 全文大小：250KB
• 参考文献：1. Winawer SI: The multidisciplinary management of gastrointestinal cancer. colorectal cancer screening. / Best Pract Res Clin Gastroenterol 2007,21(6):1031-058. CrossRef
  2. Pawilk TM, Choi MA: Surgical therapy for colorectal metastases to the liver. / J Gastrointest Surg 2007,11(8):1057-077. CrossRef
  3. Xu J, Wei Y, Zhong Y, Fan J, Zhou J, Qin L, Ren L, Qin X: Hepatectomy for liver metastasis of colorectal cancer. / Int J Colorectal Dis 2009,24(4):419-25. CrossRef
  4. Vogl TJ, Gruber T, Balzer JO, Eichler K, Hammerstingl R, Zangos S: Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. / Radiology 2009,250(1):281-89. CrossRef
  5. Vogl TJ, Zangos S, Balzer JO, Thalhammer A, Mack MG: Transarterial chemoembolization of liver metastases: indication, techniques, results. / R?fo 2002,174(6):675-83.
  6. Okuno K: Surgical treatment for digestive cancer. Current issues - colon cancer. / Dig Surg 2007,24(2):108-14. CrossRef
  7. Primrose JN: Surgery for colorectal liver metastases. / Br J Cancer 2010,102(9):1313-318. CrossRef
  8. Zorzi D, Mullen JT, Abdalla EK, Pawlik TM, Andres A, Muratore A, Curley SA, Mentha G, Capussotti L, Vauthey JN: Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. / J Gastrointest Surg 2006, 10:86-4. CrossRef
  9. Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, Barbas AS, Abdalla EK, Choti MA, Vauthey JN, Ludwig KA, Mantyh CR, Morse MA, Clary BM: Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. / Ann Surg Oncol 2007, 14:3481-491. CrossRef
  10. Martin RC, Joshi J, Robbins K, Tomalty D, O’Hara R, Tatum C: Transarterial chemoembolisation (TACE)using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. / World J Surg Oncol 2009, 7:74-0. CrossRef
  11. De Baere T, Deschamps F: Arterial therapies of colorectal cancer metastases to the liver. / Abdom Imaging 2011,36(6):661-70. CrossRef
  12. Xia J, Ren Z, Ye S, Sharma D, Lin Z, Gan Y, Chen Y, Ge N, Ma Z, Wu Z, Fan J, Qin L, Zhou X, Tang Z, Yang B: Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. / Eur J Radiol 2006,59(3):407-12. CrossRef
  13. Osuga K, Miyayama S, Yamagami T, Anai H, Takahashi M, Nakamura H: New porous gelatin particles for hepatic arterial embolization–investigation of passage through current microcatheters. / Gan To Kagaku Ryoho 2007,34(1):59-4.
  14. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. / CA Cancer J Clin 2013,63(1):11-0. CrossRef
  15. Van Cutsem E, Nordlinger B, Adam R, K?hne CH, Pozzo C, Poston G, Ychou M, Rougier P: Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. / Eur J Cancer 2006,42(14):2212-221. CrossRef
  16. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN, Vauthey JN: Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. / Ann Surg 2005,241(5):715-24. CrossRef
  17. Aliberti C, Tilli M, Benea G, Fiorentini G: Trans-arterial chemoembolization(TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. / Anticancer Res 2006, 26:3793-796.
  18. Fiorentini G, Aliberti C, Benea G, Montagnani F, Mambrini A, Ballardini PL, Cantore M: TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects. / Hepatogastroenterol 2008,55(88):2077-082.
  19. Chen Y, Yan Z, Wang J, Wang X, Luo J, Liu Q: Hepatic arterial infusion with oxaliplatin, irinotecan and doxifluridine for unresectable liver metastases of colorectal cancer. / Anticancer Res 2010,30(7):3045-049.
  20. Kemeny N, Capanu M, D’Angelica M, Jarnagin W, Haviland D, Dematteo R, Fong Y: Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal. / Cancer Ann Oncol 2009, 20:1236-241. CrossRef
  21. Vogl TJ, Zangos S, Eichler K, Yakoub D, Nabil M: Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. / Eur Radiol 2007,17(4):1025-034. CrossRef
  22. Kingham TP, D'Angelica M, Kemeny NE: Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases. / J Surg Oncol 2010,102(8):988-95. CrossRef
  23. Chen MS, Li JQ, Zhang YQ, Lu LX, Zhang WZ, Yuan YF, Guo YP, Lin XJ, Li GH: High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. / World J Gastroenterol 2002,8(1):74-8.
  24. Choi CS, Kim KH, Seo GS, Cho EY, Oh HJ, Choi SC, Kim TH, Kim HC, Roh BS: Cerebral and pulmonary embolisms after transcatheter arterial chemoembolization for hepatocellular carcinoma. / World J Gastroenterol 2008,14(30):4834-837. CrossRef
  25. Wu L, Yang YF, Liang J, Shen SQ, Ge NJ, Wu MC: Cerebral lipiodol embolism following transcatheter arterial chemoembolization for hepatocellular carcinoma. / World J Gastroenterol 2010,16(3):398-02. CrossRef
  26. Fiorentini G, Aliberti C, Turrisi G, Del Conte A, Rossi S, Benea G, Giovanis P: Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study. / In Vivo 2007,21(6):1085-091.
  27. Poggi G, Quaretti P, Minoia C, Bernardo G, Bonora MR, Gaggeri R, Ronchi A, Saluzzo CM, Azzaretti A, Rodolico G, Montagna M, Amatu A, Teragni C, Palumbo I, Traverso E, Tonini S, Villani L, Scelsi M, Baiardi P, Felisi MG, Sottotetti F, Tagliaferri B, Riccardi A: Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors. / Anticancer Res 2008,28(6):3835-842.
  28. Martin RC, Joshi J, Robbins K, Tomalty D, O'Hara R, Tatum C: Transarterial chemoembolization of metastatic colorectal carcinoma with drug-eluting beads, Irinotecan (DEBIRI): multi-institutional registry. / J Oncol 2009, 2009:539795. CrossRef
  29. Nitta N, Ohta S, Tanaka T, Takazakura R, Toyama T, Sonoda A, Seko A, Furukawa A, Takahashi M, Murata K, Kurumi Y, Tani T, Sakamoto T, Tabata Y: An initial clinical study on the efficacy of cisplatin-releasing gelatin microspheres for metastatic liver tumors. / Eur J Radiol 2009,71(3):519-26. CrossRef
  30. Wagnetz U, Jaskolka J, Yang P, Jhaveri KS: Acute ischemic cholecystitis after transarterial chemoembolization of hepatocellular carcinoma: incidence and clinical outcome. / J Comput Assist Tomogr 2010,34(3):348-53. CrossRef
  
• 作者单位：Chuang Li (3)
  Yuewei Zhang (3)
  Jun Zhou (3)
  Guangsheng Zhao (3)
  Shunxiong Tang (3)
  
  3. Department of Interventional Radiology, Affiliated Zhongshan Hospital of Dalian University, 6 Jiefang Street, Zhongshan District, Dalian, 116001, China
  

文摘

Background Colorectal cancer (CRC) is one of the most common cancers worldwide. The majority (approximately 60%) of patients with CRC will eventually develop liver metastases, which remain the most common cause of mortality in these patients. This study aimed to evaluate the therapeutic effect and tolerability of gelatin sponge particle (GSP)-mediated chemoembolization in the treatment of colorectal liver metastases after systemic chemotherapy failure. Methods This was a single-center retrospective study of 15 patients with colorectal liver metastases, who underwent GSP-mediated chemoembolization with 50 mg of lobaplatin during the period December 2009 to December 2010 in the Department of Interventional Radiology, Affiliated Zhongshan Hospital of Dalian University. Clinical data were retrieved, and the therapeutic effect and tolerability of the treatment were evaluated. Results All 15 patients with colorectal liver metastases completed the GSP-mediated chemoembolization. The therapeutic effect and tolerability were evaluated 3 months after the initial procedure. The tumor lesions in all patients showed various levels of necrosis and shrinkage. According to the Response Evaluation Criteria in Solid Tumors (RECIST), one patient achieved complete response (CR), eleven patients achieved partial response (PR), and three patients achieved stable disease (SD). The overall response rate (CR-?PR) was 80%. Conclusions GSP-mediated chemoembolization is well tolerated and has a good short-term response rate (80%) in the treatment of colorectal liver metastases after systemic chemotherapy failure. Collectively, further study of the long-term effect of GSP-mediated chemoembolization in colorectal liver metastasis in a large cohort is warranted.